Further investigations to dissect the structural and molecular basis underlying the differential effects of A-FABP in different tissues are needed in order to design more effective therapeutic interventions for obesity and its related medical complication by targeting A-FABP. The gene discussed is FABP4; the disease is obesity disorder.